These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8008404)

  • 1. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.
    Goucke RC; Hackett PL; Ilett KF
    Pain; 1994 Feb; 56(2):145-149. PubMed ID: 8008404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.
    Wolff T; Samuelsson H; Hedner T
    Pain; 1996 Dec; 68(2-3):209-16. PubMed ID: 9121807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.
    Wolff T; Samuelsson H; Hedner T
    Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine.
    Samuelsson H; Hedner T; Venn R; Michalkiewicz A
    Pain; 1993 Feb; 52(2):179-185. PubMed ID: 8455965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
    Du X; Skopp G; Aderjan R
    Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma and cerebrospinal fluid using solid-phase extraction and high-performance liquid chromatography with electrochemical detection.
    Wright AW; Watt JA; Kennedy M; Cramond T; Smith MT
    Ther Drug Monit; 1994 Apr; 16(2):200-8. PubMed ID: 8009570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
    Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
    Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
    Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C; Joel S; Patel N; Baksh A; Slevin M
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
    Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
    Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine.
    van Dongen RT; Crul BJ; Koopman-Kimenai PM; Vree TB
    Br J Clin Pharmacol; 1994 Sep; 38(3):271-3. PubMed ID: 7826830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine metabolites.
    Christrup LL
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine, morphine-6-glucuronide and morphine-3-glucuronide concentrations in plasma and cerebrospinal fluid during long-term high-dose intrathecal morphine administration.
    Bigler D; Christensen BC; Eriksen J; Jensen HN
    Pain; 1990 Apr; 41(1):15-18. PubMed ID: 2352761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic responses to intrathecal morphine in relation to CSF concentrations of morphine-3,beta-glucuronide and morphine-6,beta-glucuronide.
    Dennis GC; Soni D; Dehkordi O; Millis RM; James H; West WL; Taylor RE
    Life Sci; 1999; 64(19):1725-31. PubMed ID: 10353626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine, morphine-3-glucuronide, morphine-6-glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry-liquid chromatography in body fluids of heroin victims.
    Bogusz MJ; Maier RD; Driessen S
    J Anal Toxicol; 1997 Sep; 21(5):346-55. PubMed ID: 9288586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
    Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
    Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral morphine in cancer pain: influences on morphine and metabolite concentration.
    McQuay HJ; Carroll D; Faura CC; Gavaghan DJ; Hand CW; Moore RA
    Clin Pharmacol Ther; 1990 Sep; 48(3):236-44. PubMed ID: 2401122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
    Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
    Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An observational study examining the effects of a surgically induced inflammatory response on the distribution of morphine and its metabolites into cerebrospinal fluid.
    Wang Y; Goralski KB; Roberts DJ; Landry K; Issa ME; Sleno L; Julien LC; Wood J; Hall RI
    Can J Anaesth; 2017 Oct; 64(10):1009-1022. PubMed ID: 28710563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.
    Klepstad P; Borchgrevink PC; Dale O; Zahlsen K; Aamo T; Fayers P; Fougner B; Kaasa S
    Palliat Med; 2003 Dec; 17(8):679-87. PubMed ID: 14694919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.